Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest Adverse effect Stories

2012-02-16 14:30:00

CAPE CORAL, Fla., Feb. 16, 2012 /PRNewswire/ -- Nature's Bioceuticals, a wholly owned subsidiary of Mistral Ventures Inc. (Pinksheets: MILV) has confirmed its showcase of new products at the Natural Products Expo West Booth # 780. The annual natural, organic and healthy products trade show is set to take place March 9-11, 2012, at the Anaheim Convention Center in Anaheim, California. "Nature's Bioceuticals is honored and thrilled to be a part of Expo West this year," began Robert...

2012-02-16 11:00:00

BEDFORD, Ohio, Feb. 16, 2012 /PRNewswire/ -- Bedford Laboratories(TM) announces a nationwide voluntary recall for the following three lots of Cytarabine for Injection, USP: Cytarabine for Injection, USP 1 gram per vial - NDC #55390-133-01 Lot 2066986 - Exp. Date March 31, 2014 Lot 2111675 - Exp. Date December 31, 2013 Lot 2131148 - Exp. Date May 31, 2014 (Logo: http://photos.prnewswire.com/prnh/20070809/CLTH157LOGO ) This voluntary market recall is being conducted due to a...

2012-02-15 08:00:00

On Jan. 18th 2012, the Honorable Judge Carol E. Higbee ordered an extended deadline for the sixth wave of core discovery for the Accutane lawsuit mass tort in New Jersey. Over 7,000 lawsuits have been filed in less than three years, since Accutane was pulled off the US market. Accutane is a popular acne medication specifically made to treat people who have extreme cases of acne. The lawsuits allege that Hoffman-LaRoche, the company manufacturing Accutane, failed to warn patients on the severe...

2012-02-14 08:00:00

On Jan. 28th and Feb. 4th 2012, the Telegraph published early findings from the study of researchers at the University of Bristol on the effects of "metal-on-metal" hip replacement devices that suggest the implants could increase the risk of cancer and genetic damage. Last month the Medicines and Healthcare products Regulatory Agency (MHRA) was advised that certain types of metal-on-metal implant could cause "systemic toxicity" in the body. Investigations in the U.S. have found that the vast...

2012-02-13 07:30:00

FORT LAUDERDALE, Fla., Feb. 13, 2012 /PRNewswire/ -- Nouveau Life Pharmaceuticals (soon to be changed from Hybrid Fuels, Inc., Pink Sheets: HRID) announced today that the Company is working on a formulation of an all-natural product to help the millions of females suffering with female sexual dysfunction (FSD). Approximately 43% of American women experience sexual dysfunction. Unfortunately, pharmaceutical treatments are limited; no drugs have yet been approved for the condition in the...

2012-02-10 08:00:00

According to the US Drug Watchdog, “On Saturday February 4th 2012, we received an e-mail from a young woman, who at 19 years old, suffered a stroke, while using the birth control pill cal Yaz. She was an athlete, with no known health issues. Our Yaz, Yasmin, or generic version Ocella birth control pill initiative is now officially our most important women's health initiative ever. We are also very focused on women who used Yaz, Yasmin, or Ocella, and had a heart attack, or developed...

2012-02-10 07:36:00

FORT LAUDERDALE, Fla., Feb. 10, 2012 /PRNewswire/ -- In an effort to raise awareness of the prevalence of Erectile Dysfunction (ED), Nouveau Life Pharmaceuticals (soon to be changed from Hybrid Fuels, Inc., Pink Sheets: HRID) provides its customers published statistics regarding ED and the benefits of Azul Instant(TM) as an all-natural alternative to those suffering with the condition. Experts report that 30 million men in the United States have ED and one in 10 men in the world suffers...

2012-02-10 01:00:00

The Consumer Justice Foundation, a for-profit corporation that is staffed by professional consumer advocates and whose Web site URL can be found at http://www.sideeffectsrx.com, hereby alerts the public of the filing of an Actos side effects lawsuit in California. The CJF provides free online educational resources for the public regarding the risks regarding certain prescription medications, and the CJF is alerting the public to this Actos side effects lawsuit where the plaintiff claims that...

2012-02-07 10:09:49

ACP issues new clinical practice guideline for drug treatment of type 2 diabetes The American College of Physicians (ACP) recommends that clinicians add metformin as the initial drug treatment for most patients with type 2 diabetes when lifestyle modifications such as diet, exercise, and weight loss have failed to adequately improve high blood sugar. ACP also recommends that clinicians add a second drug to metformin when treatment with metformin and lifestyle changes fail to control...

2012-02-06 08:00:00

The US Drug Watchdog says, "We totally underestimated the number of diabetics in the United States, who used the diabetes drug called Actos, and now have bladder cancer. We now believe the number of diabetics, who used the diabetes drug called Actos, and have now developed bladder cancer could easily be in the thousands. We want to get every possible victim identified to insure they have the most capable attorneys. We can't even imagine how you put a price on this mess, but its huge." There...